title: Allogeneic Transplantation for Unfavorable-Risk Acute Myeloid Leukemia.
abstract: Acute myeloid leukemia (AML) is a complex, heterogeneous disorder that can have devastating effects. Although control of AML can be attained with various induction regimens, long-term cure is much more difficult to maintain. This is understated in patients with unfavorable-risk AML, who are usually older and have prior myeloid and/or therapy-related disease and more challenges in curing this disease.
authors: Moffitt Cancer Center, Tampa, FL. Electronic address: hugo.fernandez@moffitt.org.
authors: Hugo F
authors: HF
authors: Fernandez
mesh_terms: D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D007167:Immunotherapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D011379:Prognosis; D012307:Risk Factors; D014184:Transplantation, Homologous / Q000379:methods*
keywords: Acute myeloid leukemia; Allogeneic hematopoietic cell transplantation; Consolidation therapy; Maintenance therapy; Unfavorable risk